Free Trial

Greenridge Global Weighs in on EUDA Health FY2025 Earnings

EUDA Health logo with Medical background

Key Points

  • Greenridge Global has increased its FY2025 EPS estimate for EUDA Health to $0.02 per share, a significant change from the previous estimate of (-$0.11).
  • The current consensus estimate for EUDA Health's full-year earnings stands at (-$0.33) per share.
  • EUDA Health's stock closed at $1.69, with a 1-year low of $1.03 and a high of $6.30.
  • Five stocks to consider instead of EUDA Health.

EUDA Health Holdings Limited (NASDAQ:EUDA - Free Report) - Equities researchers at Greenridge Global upped their FY2025 EPS estimates for EUDA Health in a research note issued to investors on Wednesday, September 24th. Greenridge Global analyst W. Gregozeski now forecasts that the company will earn $0.02 per share for the year, up from their prior estimate of ($0.11). The consensus estimate for EUDA Health's current full-year earnings is ($0.33) per share.

EUDA Health Price Performance

EUDA opened at $1.69 on Friday. The stock has a fifty day moving average price of $2.25 and a 200 day moving average price of $3.19. EUDA Health has a 1 year low of $1.03 and a 1 year high of $6.30.

About EUDA Health

(Get Free Report)

EUDA Health Holdings Limited operates as a healthcare specialty company. The company operates through two segments, Medical Services and Property Management Services. It offers a range of specialty care services to patients; and operates medical facility general practice clinic that provides holistic care for various illnesses.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in EUDA Health Right Now?

Before you consider EUDA Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and EUDA Health wasn't on the list.

While EUDA Health currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.